IHS Chemical Week

Regions :: Australia/New Zealand

Lonza and Australian Firm Establish Manufacturing Alliance

11:34 AM MDT | October 6, 2011 | Deepti Ramesh

Lonza says it has entered into a strategic alliance with Mesoblast (Melbourne, Australia), a developer of innovative biological products for regenerative medicine, for clinical and long-term commercial production of Mesoblast’s off-the-shelf allogeneic adult stem cell products. The alliance will provide Mesoblast with certainty of capacity to meet long-term global supply of its proprietary mesenchymal precursor cell (MPC) products. “The cell therapy market is anticipated to become a major growth industry with the potential to mirror the growth we have...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa